JP2002053577A5 - - Google Patents

Download PDF

Info

Publication number
JP2002053577A5
JP2002053577A5 JP2001224792A JP2001224792A JP2002053577A5 JP 2002053577 A5 JP2002053577 A5 JP 2002053577A5 JP 2001224792 A JP2001224792 A JP 2001224792A JP 2001224792 A JP2001224792 A JP 2001224792A JP 2002053577 A5 JP2002053577 A5 JP 2002053577A5
Authority
JP
Japan
Prior art keywords
lower alkyl
alkyl
hetero
twice
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001224792A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002053577A (ja
Filing date
Publication date
Priority claimed from DE10036818A external-priority patent/DE10036818A1/de
Application filed filed Critical
Publication of JP2002053577A publication Critical patent/JP2002053577A/ja
Publication of JP2002053577A5 publication Critical patent/JP2002053577A5/ja
Pending legal-status Critical Current

Links

JP2001224792A 2000-07-28 2001-07-25 新規n−トリアゾリルメチル−ピペラジン誘導体、その製造方法および中間生成物、および前記誘導体を含有する医薬品 Pending JP2002053577A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10036818.2 2000-07-28
DE10036818A DE10036818A1 (de) 2000-07-28 2000-07-28 Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten

Publications (2)

Publication Number Publication Date
JP2002053577A JP2002053577A (ja) 2002-02-19
JP2002053577A5 true JP2002053577A5 (https=) 2008-06-19

Family

ID=7650544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001224792A Pending JP2002053577A (ja) 2000-07-28 2001-07-25 新規n−トリアゾリルメチル−ピペラジン誘導体、その製造方法および中間生成物、および前記誘導体を含有する医薬品

Country Status (27)

Country Link
US (1) US6407106B1 (https=)
EP (1) EP1176144B1 (https=)
JP (1) JP2002053577A (https=)
KR (1) KR100924405B1 (https=)
CN (1) CN1167698C (https=)
AR (1) AR028743A1 (https=)
AT (1) ATE244716T1 (https=)
AU (1) AU779318B2 (https=)
BR (1) BR0103048A (https=)
CA (1) CA2354213C (https=)
CZ (1) CZ301695B6 (https=)
DE (2) DE10036818A1 (https=)
DK (1) DK1176144T3 (https=)
DZ (1) DZ3119A1 (https=)
ES (1) ES2201007T3 (https=)
HU (1) HU226687B1 (https=)
IL (1) IL144299A (https=)
IN (1) IN191021B (https=)
NO (1) NO323233B1 (https=)
NZ (1) NZ513041A (https=)
PL (1) PL210436B1 (https=)
PT (1) PT1176144E (https=)
RU (1) RU2288918C2 (https=)
SK (1) SK284802B6 (https=)
TW (1) TWI304403B (https=)
UA (1) UA73728C2 (https=)
ZA (1) ZA200105737B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA77515C2 (en) 2002-04-04 2006-12-15 Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity
KR100755577B1 (ko) * 2002-04-26 2007-09-12 일라이 릴리 앤드 캄파니 타키키닌 수용체 길항제로서의 트리아졸 유도체
BR0309486A (pt) * 2002-04-26 2005-02-09 Lilly Co Eli Composto ou um seu sal farmaceuticamente aceitável, composição farmacêutica, e, método para o tratamento de uma condição associada com um excesso de taquicininas
EP1638944A1 (en) * 2003-06-12 2006-03-29 Eli Lilly And Company Tachykinin receptor antagonists
US20070082905A1 (en) * 2005-05-27 2007-04-12 De Vries Michiel H Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using same
ES2353724T3 (es) * 2005-07-25 2011-03-04 F. Hoffmann-La Roche Ag Derivados de triazol substitutidos y su uso como antagonistas del receptor neuroquinina 3.
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
WO2008090114A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
WO2011020874A1 (en) 2009-08-20 2011-02-24 Inserm (Institut National De La Sante Et De La Recherche Medicale) Vla-4 as a biomarker for prognosis and target for therapy in duchenne muscular dystrophy
WO2013004766A1 (en) 2011-07-04 2013-01-10 Ferrari Giulio Nk-1 receptor antagonists for treating corneal neovascularisation
CN111918647A (zh) 2018-02-26 2020-11-10 圣拉斐尔医院有限公司 用于治疗眼痛的nk-1拮抗剂
WO2021180885A1 (en) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency
CN115184498B (zh) * 2022-07-15 2023-02-21 山东京卫制药有限公司 N-Boc-哌嗪中有关物质哌嗪的检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883098A (en) 1993-11-29 1999-03-16 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
IL111730A (en) 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US5637592A (en) * 1994-07-12 1997-06-10 Janssen Pharmaceutica N.V. Acyl derivatives of azolones
WO1997022597A1 (en) * 1995-12-18 1997-06-26 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives as tachykinin antagonists
CN1072220C (zh) * 1995-05-25 2001-10-03 藤泽药品工业株式会社 作为神经激肽受体拮抗剂的1-苯甲酰基-2-(吲哚基-3-烷基)-哌嗪衍生物
GB9513118D0 (en) * 1995-06-28 1995-08-30 Merck Sharp & Dohme Therapeutic agents
KR100458346B1 (ko) * 1996-03-29 2005-06-21 듀파 인터내셔날 리서치 베 파우 피페라진및피페리딘화합물
AUPO735997A0 (en) * 1997-06-17 1997-07-10 Fujisawa Pharmaceutical Co., Ltd. Piperazine derivatives
DE19824865A1 (de) 1997-08-27 1999-03-04 Solvay Pharm Gmbh Neue Harnstoffderivate
EP0899270B1 (de) * 1997-08-27 2008-05-21 Solvay Pharmaceuticals GmbH Indolmethyl-N,N'-bisacylpiperazine als Neurokininrezeptorantagonisten
ES2162731B1 (es) * 1999-06-04 2003-02-16 Faes Fabrica Espanola De Produ Nuevas arilpiperacilnilalquil-3(2h)-piridacinonas.

Similar Documents

Publication Publication Date Title
JP2002053577A5 (https=)
JP2006521359A5 (https=)
JP2004532240A5 (https=)
JP2005508905A5 (https=)
JP2006524225A5 (https=)
JP2007530696A5 (https=)
JP2013528180A5 (https=)
JP2005539088A5 (https=)
JP2008505117A5 (https=)
JP2005508967A5 (https=)
JP2009534398A5 (https=)
JP2009530424A5 (https=)
CA2387013A1 (en) 6-position substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
JP2011511075A5 (https=)
NO20012288L (no) Gastrin- og kolecystokinin-reseptorligander
JP2012510502A5 (https=)
JP2004002414A5 (https=)
FI102752B (fi) Menetelmä verenpainetta alentavien 4-alkyyli-imidatsolijohdannaisten v almistamiseksi
JP2010504930A5 (https=)
JP2005527542A5 (https=)
JP2006523193A5 (https=)
NO20053762L (no) Kondensert furanforbindelse.
KR960701878A (ko) 수용성 캄프토테신 유도체, 이의 제조 방법 및 항종양제로서의 이의 용도(Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents)
RU2002107318A (ru) Новые фенилпиперазины
JP2001525394A5 (https=)